These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 4273761)

  • 1. Brain biogenic amine depletion and mood.
    Mendels J; Frazer A
    Arch Gen Psychiatry; 1974 Apr; 30(4):447-51. PubMed ID: 4273761
    [No Abstract]   [Full Text] [Related]  

  • 2. Biogenic amines and affective disorders. A critical analysis.
    Luchins D
    Int Pharmacopsychiatry; 1976; 11(3):135-49. PubMed ID: 136425
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Social environment and brain biogenic amine metabolism in rats.
    Stolk JM; Conner RL; Barchas JD
    J Comp Physiol Psychol; 1974 Aug; 87(2):203-7. PubMed ID: 4279254
    [No Abstract]   [Full Text] [Related]  

  • 4. Importance of central catecholamines in the mediation of lordosis behaviour in ovariectomized rats treated with estrogen and inhibitors of monoamine synthesis.
    Ahlenius S; Engel J; Eriksson H; Modigh K; Södersten P
    J Neural Transm; 1972; 33(4):247-55. PubMed ID: 4264740
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between brain monoamine levels and Sidman avoidance behavior in rats treated with tyrosine and tryptophan hydroxylase inhibitors.
    Tanaka C; Yo YJ; Takaori S
    Brain Res; 1972 Oct; 45(1):153-64. PubMed ID: 4403884
    [No Abstract]   [Full Text] [Related]  

  • 6. Proceedings: Amine depletion as an experimental approach to the aminergic hypothesis.
    Mendels J
    Psychopharmacol Bull; 1974 Oct; 10(4):54-6. PubMed ID: 4279415
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC.
    Johnston RR; Way WL; Miller RD
    Anesthesiology; 1974 Jul; 41(1):57-61. PubMed ID: 4275974
    [No Abstract]   [Full Text] [Related]  

  • 8. Monoaminergic control of episodic growth hormone secretion in the rat: effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine, and haloperidol.
    Edén S; Bolle P; Modigh K
    Endocrinology; 1979 Aug; 105(2):523-9. PubMed ID: 156637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of drugs that modify brain monoamine concentrations on plasma gonadotropin and prolactin levels in the rat.
    Donoso AO; Bishop W; Fawcett CP; Krulich L; McCann SM
    Endocrinology; 1971 Sep; 89(3):774-84. PubMed ID: 4254791
    [No Abstract]   [Full Text] [Related]  

  • 10. Biogenic amines and acute thermal stress in the rat.
    Williams BA; Moberg GP
    Comp Biochem Physiol C Comp Pharmacol; 1975 Jun; 51(1):67-71. PubMed ID: 239827
    [No Abstract]   [Full Text] [Related]  

  • 11. Biogenic amines and narcotic effects. I. Modification of morphine-induced analgesia and motor activity after alteration of cerebral amine levels.
    Buxbaum DM; Yarbrough GG; Carter ME
    J Pharmacol Exp Ther; 1973 May; 185(2):317-27. PubMed ID: 4267383
    [No Abstract]   [Full Text] [Related]  

  • 12. Brain amine levels and competitive behavior between rats in a straight runway.
    Masur J; Czeresnia S; Skitnevsky H; Carlini EA
    Pharmacol Biochem Behav; 1974; 2(1):55-62. PubMed ID: 4275179
    [No Abstract]   [Full Text] [Related]  

  • 13. [Activity of the hypophyseal-adrenal system under the influence of substances of mediator type action].
    Saponov NS; Ryzhenkov VE
    Probl Endokrinol (Mosk); 1975; 21(4):47-51. PubMed ID: 131938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of some synthetic analogues of ACTH on the metabolism of biogenic amines in the rat brain.
    Leonard BE
    Br J Pharmacol; 1972 Nov; 46(3):560P-561P. PubMed ID: 4348184
    [No Abstract]   [Full Text] [Related]  

  • 15. Neurochemical changes following the administration of depleters of biogenic monoamines.
    Lane JD; Smith JE; Shea PA; McBride WJ
    Life Sci; 1976 Dec; 19(11):1663-7. PubMed ID: 12434
    [No Abstract]   [Full Text] [Related]  

  • 16. Reserpine-induced alterations in brain amines and their relationship to changes in the incidence of minimal electroshock seizures in mice.
    Azzaro AJ; Wenger GR; Craig CR; Stitzel RE
    J Pharmacol Exp Ther; 1972 Mar; 180(3):558-68. PubMed ID: 4258979
    [No Abstract]   [Full Text] [Related]  

  • 17. Amines and abnormal mood.
    Dewhurst WG
    Proc R Soc Med; 1969 Nov; 62(11 Part 1):1102-7. PubMed ID: 5356863
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of morphine on intracranial self-stimulation behavior following brain amine depletion.
    Pert A; Hulsebus R
    Life Sci; 1975 Jul; 17(1):19-20. PubMed ID: 124807
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of lesions and drugs on brain tryptamine.
    Marsden CA; Curzon G
    J Neurochem; 1974 Dec; 23(6):1171-6. PubMed ID: 4281442
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of depletion of cerebral monoamines on the concentration of glycogen and on amphetamine-induced glycogenolysis in the brain.
    Hutchins DA; Rogers KJ
    Br J Pharmacol; 1973 May; 48(1):19-29. PubMed ID: 4269287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.